Our first UAC Career Day brought alumni + PhD students together for real talk on life after the degree.
From diagnostics to policy, every path was different and every insight valuable!
Huge thanks to our speakers!
📎 Recap: uu.se/en/centre/uppsala-anti…#AMR#phdlife#researchcareers
🎙️Ep61 of #theAMRstudio:
Join us as we talk with Prof. Arnér about his work in redox biology & the development of the novel antibiotic candidate, EbsArgent. We also explore:
Resistance of Ceftazidime-avibactam
Mechanisms behind FusB-mediated resistance
uu.se/en/centre/uppsala-anti…
🎙️ New episode of #TheAMRStudio is out!
We speak with Vance Fowler, co-lead of the @ARLGnetwork, about his decades research and the work of the ARLG.
In the news, hear about our student's recent paper on a method to study AMR dynamics in farms, and more!
uu.se/en/centre/uppsala-anti…
Join us for our next webinar on Friday March 7th! Our students Filip Ilievski & Carla Sacchi will present their work on #BacterialTranslation & #antibiotic R&D innovation with a #sustainability twist!
Grab your lunch and coffee and join us at
bit.ly/UACmar25
Today we are at the 1st conference on #AntibioticResistance organized by @Vetenskapsradet with special focus on practice, product & policy.
Our director opened the meeting talking about our #multidisciplinary approach to research & education, including our Nordic collaboration!
🚀 The 2025 season kicks off at #theAMRstudio!
We talk to Dr. Evangelos Mourkas, a vet-turned-computational biologist tackling AMR in the field & lab. Plus, we cover new research on probiotics & plasmid-chromosome cross-talk!
🎧 Listen: bit.ly/AMRep58#AMR#SciComm
No better way to wrap up a week than by learning! Next week’s Friday, Feb 7th (12:30-14:00 CET), we kickstart our 2025 webinar season, this year featuring our PhD students and all things #AMR. Next: Bacterial #hybrids 🧬 & #DrugDelivery 💊
👉🏻Join us at bit.ly/UACfeb25
UAC is now opening its research school to all PhD students at Uppsala University & the Swedish University of Agricultural Sciences @_SLU!
Are you doing your PhD on a topic relating to #AMR and/or #resistance? Then you might want to join!
Learn more at: bit.ly/UACschool
Excellent News 👉 #Antibiotic#development platform ENABLE-2 is granted SEK 25 million annually through 2028 as part of the Swedish Research Bill ✅ "This is sending an encouraging message to both Sweden and Europe," states Anders Karlén 👍 Learn more ➡️ uu.se/en/department/medicina…
🚨 More Big News! 🚨 We have secured funding for 2025-2028! This means enhanced activities in education, and international collaboration, with a brand new associated phd research school in #AMR 🌍🔬
Keep an eye out for our new open program early 2025!
👇
uu.se/en/centre/uppsala-anti…
New Episode Alert! 🎧
Listen to @OlivierRubin, who shares his expertise on #AMR as a “creeping crisis,” drawing on parallels with climate change and famine governance. 🌍 With him, we gain new perspectives on this global challenge
Check the episode page👇
uu.se/en/centre/uppsala-anti…
Big News! @UU_University has secured 48 million SEK for research on #AMR on the latest @Vetenskapsradet calls! This funding supports innovative projects including new diagnostics, treatments, and behavior-focused solutions, among other topics!
Read more👇
uu.se/en/centre/uppsala-anti…
On the agenda: Nordic collaboration to ensure access to essential antibiotics. The Swedish Medical Products Agency, in collaboration with the Nordic Council of Ministers, is hosting a conference where Lif’s Bengt Mattson is providing the pharmaceutical industry's insights on this crucial issue. #AMR
UAC alumni Dr. Carl Björvang on the stage at the conference on #antibiotic access! Carl has worked at his new position at @TLV_nyheter on assessing the efficiency of proposed pull incentives models. Results show a Netflix-like model with #stewardship commitments as the best one!
This week we learn about the access to #antibiotics in the Nordic Region 🇸🇪 🇩🇰 🇳🇴 🇫🇮, in a conference organized by the @LV_MPA
Impressive comprehensive program exploring key concepts & processes, from R&D to market use.
How do we ensure access in a world with increased #AMR?
The last two talks of today brought us two additional important aspects of #AMR: @acu_IDlab presented her labs work with surveillance of plasmid-mediated resistance in patients, and Sunghoon Kwon described their work creating a platform for ultra rapid testing for sepsis
Afternoon session focusing on alternative therapeutic options for the sickest patients. When nothing else works, what can we do? @victornizet brings us his work on #nanotechnology with cool nanosponges, while Dongeun Yong talks about #PhageTherapy and its cumbersome process